It showed that FBXL10 exhibited relative higher expression in the breast cancer cells with mesenchymal-like morphology and aggressive character (BT474, MDA-MB-231, and BT549) (Fig. 2A), this result was consistent with our bioinformatics analysis and Kottakis’s research reported previously [44]. This evidence concerns the gene KDM2B and breast cancer.